These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 26203689)

  • 1. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
    Chen Y; Deng Y; Zhu C; Xiang C
    Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA.
    Dong S; Zhou X; Yang J
    Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
    Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
    Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer.
    Hoang B; Ernsting MJ; Murakami M; Undzys E; Li SD
    Int J Pharm; 2014 Aug; 471(1-2):224-33. PubMed ID: 24853460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system.
    Chen W; Guo M; Wang S
    Drug Dev Ind Pharm; 2016 Dec; 42(12):1968-1976. PubMed ID: 27143168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
    Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System.
    Qu Z; Ren Y; Shen H; Wang H; Shi L; Tong D
    Drug Des Devel Ther; 2021; 15():3605-3616. PubMed ID: 34447241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
    Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
    Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
    Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α
    Qiu J; Cai G; Liu X; Ma D
    Biomed Pharmacother; 2017 Dec; 96():1418-1426. PubMed ID: 29079344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.